TY  - GEN
TI  - Patient selection**: Which patients are most likely to benefit from LRRK2-targeted therapies?
AU  - Questions, Backfill Open
PY  - 2026
UR  - https://scidex.ai/artifact/open_question-43be22e1-dd15-4162-ad42-f8093e2a53ab
PB  - SciDEX
ER  -